| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/29/1999 | CA2306085A1 Intra-cancer-cell nuclease activator |
| 04/29/1999 | CA2287485A1 Novel method for obtaining microspheres and resulting products |
| 04/29/1999 | CA2275773A1 Oral cyclosporin formulations |
| 04/28/1999 | EP0911323A1 Biologically useful conjugates |
| 04/28/1999 | EP0911039A2 Drug-resin complexes stabilized by chelating agents |
| 04/28/1999 | EP0911038A1 Anhydrous composition comprising lactulose |
| 04/28/1999 | EP0911036A2 Dual carrier immunogenic construct |
| 04/28/1999 | EP0911033A2 Methods and compositions for the treatment of diseases with interferon while reducing side effects |
| 04/28/1999 | EP0911024A2 Use of water-soluble or water-dispersible polyurethans as coating agents or binders for pharmaceutical administration forms |
| 04/28/1999 | EP0911023A1 Pharmaceutical or cosmetic compositions containing photosensitizing substances |
| 04/28/1999 | EP0911021A2 Methods and compositions for fine lines and/or wrinkles |
| 04/28/1999 | EP0911016A1 Use of ascorbyl-2-phosphoric acid esters for stabilising vitamin a and/or vitamin a-derivatives in cosmetic and pharmaceutic compositions |
| 04/28/1999 | EP0910632A2 Presentation of antigen, introduced into the cells by stimulation of macropinocytosis |
| 04/28/1999 | EP0910413A2 TREATMENT OF ASTHMA WITH TNFR-Ig |
| 04/28/1999 | EP0910412A1 Hydrolysable hydrogels for controlled release |
| 04/28/1999 | EP0910411A1 Hydrophobic preparations containing medium chain monoglycerides |
| 04/28/1999 | EP0910408A1 DELIVERY SYSTEM USING mAb 3E10 AND MUTANTS AND/OR FUNCTIONAL FRAGMENTS THEREOF |
| 04/28/1999 | EP0910402A1 Insulin preparations containing carbohydrates |
| 04/28/1999 | EP0910399A1 Stable pharmaceutical composition of bdnf |
| 04/28/1999 | EP0910390A1 Pharmaceutical compositions containing alkylaryl polyether alcohol polymer |
| 04/28/1999 | EP0910388A1 Pharmaceutical preparation for the treatment of gastritis, reflux oesophagitis, duodenitis, dyspepsia and ulcer disease |
| 04/28/1999 | EP0910364A1 Buffered compositions containing a local anaesthetic and used as an anti-inflammatory |
| 04/28/1999 | EP0910353A1 Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents |
| 04/28/1999 | EP0910349A2 Controlled release tablet |
| 04/28/1999 | EP0910348A1 Locally administrable, biodegradable and sustained-release pharmaceutical composition for periodontitis and process for preparation thereof |
| 04/28/1999 | EP0910346A2 Marking rapidly disintegrating dosage forms |
| 04/28/1999 | EP0910343A1 Emulsion formulations for hydrophilic active agents |
| 04/28/1999 | EP0910342A1 Temperature sensitive gel for sustained delivery of protein drugs |
| 04/28/1999 | EP0691886B1 Microcapsules with walls made of cross-linked plant polyphenols, and compositions containing same |
| 04/28/1999 | EP0559738B1 Methods for detection and quantitation of cell subsets within subpopulations of a mixed cell population |
| 04/28/1999 | EP0295248B2 Liposome preparation and antibiotic |
| 04/28/1999 | CN1215340A Composition comprising interleukin-1 inhibitor and controlled release polymer |
| 04/28/1999 | CN1215339A 5 'alpha'-reductase inhibitory preparation for oral administration, process for producing the same, and use thereof |
| 04/28/1999 | CN1215331A Injection formulations of avermectins and milbemycins based on castor oil |
| 04/28/1999 | CN1215330A Antiseptic skin care composition and method for making same |
| 04/28/1999 | CN1215309A Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof |
| 04/27/1999 | US5898034 Psoriasis medication and application for remission and/or cure of plaque psoriasis |
| 04/27/1999 | US5898033 Antiinflammatory non-immunogenic conjugate comprising polyamino acid backbone having multiplicity of molecules of non-steroidal antiinflammatory agent linked thereto, which is preferentially internalized by antigen-processing cells |
| 04/27/1999 | US5898030 hGH containing pharmaceutical compositions |
| 04/27/1999 | US5897880 Topical drug preparations |
| 04/27/1999 | US5897876 A water-in-oil emulsion comprising a continuous hydrophobic phase and a discontinuous aqueous hydrophilic phase, surfactant dispersants and active drug for oral delivery |
| 04/27/1999 | US5897861 Bispecific molecule comperises a binding specificity for an envelope glycoprotein of human immunodeficiency virus which binds to a region that is highly conserved between isolates of hiv, and an antibody or fragment |
| 04/27/1999 | CA2134987C Substained release alginate fibre and process for the preparation thereof |
| 04/27/1999 | CA2127581C Process for preparing spherules |
| 04/27/1999 | CA2117726C Oil-in-water emulsion for the preparation of a cream |
| 04/27/1999 | CA2105079C Composition and method for delivery of drugs |
| 04/27/1999 | CA2059523C Pharmaceutical compositions |
| 04/27/1999 | CA2058959C A fructose-based granulated product and a process for the production th ereof |
| 04/22/1999 | WO1999019359A1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 04/22/1999 | WO1999019011A1 Anti-caking agents |
| 04/22/1999 | WO1999019000A1 Controlled size polymeric microspheres with superparamagnetic cores |
| 04/22/1999 | WO1999018999A1 Compositions for controlling bacterial colonization |
| 04/22/1999 | WO1999018998A2 Delivery system |
| 04/22/1999 | WO1999018995A1 Immunogenic peptides from the hpv e7 protein |
| 04/22/1999 | WO1999018994A1 Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution |
| 04/22/1999 | WO1999018987A1 Ligand binding site of rage and uses thereof |
| 04/22/1999 | WO1999018973A2 Liquid presentations of oxazaphosphorine-containing pharmaceutical products |
| 04/22/1999 | WO1999018972A1 New improved formulation for treatment of osteoporosis |
| 04/22/1999 | WO1999018967A1 Analgesic compositions |
| 04/22/1999 | WO1999018966A1 Parenteral formulations comprising carbamazepine or its derivatives |
| 04/22/1999 | WO1999018963A1 Use of flunarizine for the topical treatment of glaucoma |
| 04/22/1999 | WO1999018959A1 Pharmaceutical formulation comprising glycine as a stabilizer |
| 04/22/1999 | WO1999018955A1 Percutaneously absorbable preparation |
| 04/22/1999 | WO1999018939A1 Methods of treating capsules and dry, powdered pharmaceutical formulations |
| 04/22/1999 | WO1999018938A1 Delayed total release gastrointestinal drug delivery system |
| 04/22/1999 | WO1999018935A1 Preparation of a directly mouldable tabletting auxiliary |
| 04/22/1999 | WO1999018932A1 Novel once-a-day controlled release sulfonylurea formulation |
| 04/22/1999 | WO1999018918A1 Water dispersible perfluoroether polymer encapsulates |
| 04/22/1999 | WO1999006011A3 Shellac-containing cosmetic product |
| 04/22/1999 | WO1999003501A9 Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae polysaccharide |
| 04/22/1999 | WO1999003454A9 Biodegradable macromers for the controlled release of biologically active substances |
| 04/22/1999 | WO1999001118A3 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 04/22/1999 | WO1998052590A3 Improved delivery of disease modifiers |
| 04/22/1999 | WO1998048837A9 Polyalkylene oxide-modified single chain polypeptides |
| 04/22/1999 | WO1998044143A9 Polymer-modified viruses |
| 04/22/1999 | WO1998044021A9 Biodegradable terephthalate polyester-poly(phosphate) polymers, compositions, articles, and methods for making and using the same |
| 04/22/1999 | WO1998043618A9 Use of cytoskeletal inhibitors for the prevention of restenosis |
| 04/22/1999 | WO1998030203A3 Transdermal therapeutic system |
| 04/22/1999 | WO1997038729A8 In vivo gene transfer methods for wound healing |
| 04/22/1999 | DE19845339A1 Directly compressible tabletting aid |
| 04/22/1999 | DE19746432A1 Emulsifying plant extracts in cold pressed olive oil using mixing mill with structured rotating disks and magnets in hermetically sealed mixing vessel |
| 04/22/1999 | DE19745950A1 Drug carrier particle for site specific drug delivery, especially to CNS |
| 04/22/1999 | CA2308143A1 Pharmaceutical formulation comprising glycine as a stabilizer |
| 04/22/1999 | CA2306479A1 Percutaneously absorbable preparation |
| 04/22/1999 | CA2306459A1 Compositions for controlling bacterial colonization |
| 04/22/1999 | CA2306440A1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 04/22/1999 | CA2306206A1 Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution |
| 04/21/1999 | EP0909766A2 Urethane-modified non ionic celluloses, a process for their production and their use as thickening additive |
| 04/21/1999 | EP0909564A1 Erythropoietin solution preparation |
| 04/21/1999 | EP0909562A1 Injections containing lipid a analogues and process for the preparation thereof |
| 04/21/1999 | EP0909558A2 Chroman derivative containing ophthalmic solution |
| 04/21/1999 | EP0909277A2 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods |
| 04/21/1999 | EP0909274A1 Methods for purification and use of erythropoietin binding protein |
| 04/21/1999 | EP0909184A2 Targeted drug delivery using sulfonamide derivatives |
| 04/21/1999 | EP0909183A2 Dha-pharmaceutical agent conjugates |
| 04/21/1999 | EP0909177A1 Aqueous formulations of peptides |
| 04/21/1999 | EP0909175A1 Non-aqueous protic peptide formulations |
| 04/21/1999 | EP0909166A2 Medicated chewing gum with a pleasant taste containing an inclusion complex |
| 04/21/1999 | EP0909158A1 Aqueous product comprising oil microdroplets stabilized by in-situ polymerized vinyl monomer and a thickening agent |
| 04/21/1999 | EP0868172A4 Direct compression carbonyl iron tablet |